Dimitropoulos, Alexandra
Rosado, Carlos J.
Thomas, Merlin C.
Funding for this research was provided by:
National Health and Medical Research Council (Senior Research Fellowship)
Article History
Received: 4 December 2019
Accepted: 5 March 2020
First Online: 13 March 2020
Compliance with ethical standards
:
: MCT and CJR have filed patents pertaining to the Receptor of Advanced Glycation End-products (RAGE). AD has no conflict of interest.
: This article is a review of the literature, and as such, its compilation or submission did not require formal informed consent from human participants and/or animals, or ethical clearance according to standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.